3160-40-5 + 1076-38-6 = 81-82-3 反应条件:1.1 Solvents: Dimethyl Sulfoxide,Water; 33 H,50 °C 标题:Synthesis Of Anticoagulant Warfarin And Its Derivatives By The Crude Earthworm Extract 作者:Li,Zhilin; Et Al 参考文献:Youji Huaxue 日期:2017 卷标:37(6) 页码:1494-1500]
3506-75-0 + 1076-38-6 = 81-82-3 反应条件:1.1 Reagents: Tempo,Propanoic Acid,2,2-Dimethyl-,Potassium Salt (1:1) Catalysts: Cupric Acetate,2,2′-Bipyridine Solvents: Dimethylformamide,Acetonitrile; 24 H,120 °C 标题:Direct Synthesis Of Alkylated 4-Hydroxycoumarin Derivatives Via A Cascade Cu-Catalyzed Dehydrogenation/conjugate Addition Sequence 作者:Chen,Zhiliang; Et Al 参考文献:Chemical Communications (Cambridge 日期:2023 卷标:59(44) 页码:6686-6689]
104-88-1 + 1076-38-6 + 116-11-0 = 81-82-3 反应条件:1.1 Reagents: Ethylenediamine Acetate Solvents: 1,4-Dioxane2.1 Reagents: Trifluoroacetic Acid Solvents: Water 标题:An Asymmetric Approach To Coumarin Anticoagulants Via Hetero-Diels-Alder Cycloaddition 作者:Cravotto,G.; Et Al 参考文献:Tetrahedron: Asymmetry 日期:2001 卷标:12(5) 页码:707-709]
= 81-82-3 反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Water 标题:An Asymmetric Approach To Coumarin Anticoagulants Via Hetero-Diels-Alder Cycloaddition 作者:Cravotto,G.; Et Al 参考文献:Tetrahedron: Asymmetry 日期:2001 卷标:12(5) 页码:707-709]
= 81-82-3 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Acetone,Water; 6 H,40 - 45 °C1.2 Reagents: Sodium Hydroxide Solvents: Water1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1 - 2 标题:Synthesis Of Coumarin Anticoagulant And Its Analogues 作者:Shen,Dong-Sheng; Et Al 参考文献:Yingyong Huaxue 日期:2005 卷标:22(10) 页码:1158-1160]
1076-38-6 + 30626-03-0 = 81-82-3 反应条件:1.1 Catalysts: 1,5,7-Triazabicyclo[4.4.0]Dec-5-Ene (Poly(Chloromethylpolystyrene)-Supported) Solvents: Cyclopentyl Methyl Ether; 96 H,100 °C 标题:Synthesis And Characterization Of Novel Polystyrene-Supported Tbd Catalysts And Their Use In The Michael Addition For The Synthesis Of Warfarin And Its Analogues 作者:Alonzi,Matteo; Et Al 参考文献:Journal Of Catalysis 日期:2014 卷标:309 页码:260-267]
3160-40-5 + 1076-38-6 = 81-82-3 反应条件:1.1 Catalysts: N-[(1S,2S)-2-Amino-1,2-Diphenylethyl]-N′-(Phenylmethyl)Thiourea Solvents: 1,4-Dioxane; 55 H,25 °C 标题:Highly Effective And Enantioselective Michael Addition Of 4-Hydroxycoumarin To α,β-Unsaturated Ketones Promoted By Simple Chiral Primary Amine Thiourea Bifunctional Catalysts 作者:Mei,Ren-Qiang; Et Al 参考文献:Tetrahedron Letters 日期:2011 卷标:52(14) 页码:1566-1568]
3160-40-5 + 1076-38-6 = 81-82-3 反应条件:1.1 Solvents: Ethanol; 12 H,Reflux2.1 Reagents: Hydrochloric Acid Solvents: Acetone,Water; 6 H,40 - 45 °C2.2 Reagents: Sodium Hydroxide Solvents: Water2.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1 - 2 标题:Synthesis Of Coumarin Anticoagulant And Its Analogues 作者:Shen,Dong-Sheng; Et Al 参考文献:Yingyong Huaxue 日期:2005 卷标:22(10) 页码:1158-1160
专利号:WO-03050105-A2 优先权日:2001-12-10 标题 :Catalytic asymmetric synthesis of optically active compounds 发明人:HALLAND NIS; JOERGENSEN KARL ANKER; HANSEN TORE 权利人:CHEMINOVA AS; HALLAND NIS; JOERGENSEN KARL ANKER; HANSEN TORE 摘要:A one step catalytic asymmetric process for the synthesis of an optically active compound of formula la or lb wherein R is selected from C1-7 alkyl, C1-7 haloalkyl, C1-7 alkoxy, C1-7 haloalkoxy, halogen and hydroxy; R3 is H or C1-4 alkyl; R4 is selected from H, C1-7 alkyl, C1-7 haloalkyl, C1-7 alkoxy, COOH, CO-C1-7 alkoxy and an optionally substituted aryl or heterocycle; AR represents C1-7 alkyl, optionally substituted aryl, an optionally substituted heterocycle or AR and R4 may be bridged together forming part of a ring system; X is O or S; m is a number between 0-4; comprising the step of reacting a compound of the formula 2 with a compound of formula 3 in the presence of a catalytic amount of a chiral nitrogen containing organic compound.
专利号:WO-2025056767-A1 优先权日:2023-09-15 标题 :Process for the preparation of enantiomerically enriched aliphatic amines 发明人:BOU HAMDAN FARHAN; GODINEAU EDOUARD; SMEJKAL TOMAS; DUMEUNIER RAPHAEL; BOUSSEMGHOUNE MOHAMED ABDELOUAHAB; BLUM MATHIAS 权利人:SYNGENTA CROP PROTECTION AG 摘要:The present invention relates to a process for the preparation of enantiomerically enriched cyclobutylamines of formula (I) from α-tertiary cyclobutanones and reacting said enantiomerically enriched cyclobutylamines to enantiomerically enriched cyclobutylamides. Such compounds are useful intermediates in the synthesis of microbiocidal thiazole compounds.
专利号:WO-2021074309-A1 优先权日:2019-10-16 标 题:1-(3-quinolyl)-3,4-dihydroisoquinoline derivatives as fungicides for combating specific phytopathogens 发明人:WEISS MATTHIAS; QUARANTA LAURA; BOU HAMDAN FARHAN; MAHAJAN ATUL; WILLIAMS SIMON; KILARU JAGADEESH; SEN INDIRA; BIERI STEPHANE; DIGGELMANN MARTIN 权利人:SYNGENTA CROP PROTECTION AG 摘要:1-(3-quinolyl)-3,4-dihydroisoquinoline derivatives of formula (I) as well as a method of combating, preventing or controlling the phytopathogens Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale), which comprises applying to the phytopathogen, to the locus of the phytopathogen, or to a plant susceptible to attack by the phytopathogen, or to propagation material thereof, a fungicidally effective amount of a 1-(3-quinolyl)-3,4-dihydroisoquinoline derivative of formula (I). The present description discloses the synthesis of exemplary compounds, formulation examples, relevant biological data (antifungal activity against Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale) when spayed on plants), as well as comparative data against three prior art compounds (e.g. pages 52 to 85; formulation examples; examples A1 to A3; table E; compounds E.01 to E.187; biological examples). Exemplary compounds are e.g.: 5-bromo-1-(8-fluoro-3-quinolyl)spiro[4H-isoquinoline-3,1'- cyclopropane] (example A1) 5-bromo-1-(8-fluoro-3-quinolyl)-3,3-dimethyl-4H-isoquinoline (example A2) 1-(8-fluoro-3-quinolyl)-3,3-dimethyl-4H-isoquinoline-5-carbonitrile (example A3)
专利号:WO-2021074311-A1 优先权日:2019-10-16 标题:1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives as fungicides for combating specific phytopathogens 发明人:WEISS MATTHIAS; QUARANTA LAURA; BOU HAMDAN FARHAN; MAHAJAN ATUL; WILLIAMS SIMON; KILARU JAGADEESH; BIERI STEPHANE; DIGGELMANN MARTIN 权利人:SYNGENTA CROP PROTECTION AG 摘要:1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives of formula (I) as well as a method of combating, preventing or controlling the phytopathogens Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale), which comprises applying to the phytopathogen, to the locus of the phytopathogen, or to a plant susceptible to attack by the phytopathogen, or to propagation material thereof, a fungicidally effective amount of a 1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives of formula (I). The present description discloses the synthesis of exemplary compounds, formulation examples, relevant biological data (antifungal activity against Mycosphaerella graminicola, Monographella nivalis, Fusarium culmorum and/or Gibberella zeae when spayed on plants) (e.g. pages 47 to 55; examples A1 and A2; compounds E.01 to E.17; table E). An exemplary compounds is e.g.: 3-(5-bromo-3,3-dimethyl-2,4-dihydro-1 H-isoquinolin-1-yl)-8-fluoro- quinoline (example A1)
专利号:WO-2021009026-A1 优先权日:2019-07-12 标 题 :Methyl 2-[(4-methoxyimino-tetralin-6-yl]prop-2-enoate derivatives, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1h-isobenzofurane and indane analogues thereof, and similar compounds, as agrochemical fungicides 发明人:WEISS MATTHIAS; WILLIAMS SIMON; RENDINE STEFANO; BOU HAMDAN FARHAN; HOFFMAN THOMAS; QUARANTA LAURA 权利人:SYNGENTA CROP PROTECTION AG 摘要:Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides, especially as fungicides. The present description discloses the synthesis and characterisation of exemplary compounds as well as biological data thereof (e.g. pages 53 to 78; examples 1 to 10; table T1; compounds 1.1 to 1.54; examples A and B). Preferred compounds are e.g.: Methyl (E)-3-methoxy-2-[(4E)-4-methoxyimino-7-methyl-tetralin-6- yl]prop-2-enoate (example 2; compound 1.6 of table T1): (Formula (A)). Methyl (E)-3-methoxy-2-[(4Z)-4-methoxyiminoisochroman-6-yl]prop-2- enoate (example 6; compound 1.39 of table T1): (Formula (B))
1: WANNTORP H. Studies on chemical determination of warfar in and coumachlor and their toxicity for dog and swine. Acta Pharmacol Toxicol (Copenh). 1959;16(Suppl 2):1-123. doi: 10.1007/s11356-016-6743-9. Epub 2016 May 4. doi: 10.12834/VetIt.118.333.3. doi: 10.1093/jat/bkt036. Epub 2013 May 10. doi: 10.1002/elps.201500367. Epub 2015 Oct 7. doi: 10.1177/1040638713501510. Epub 2013 Sep 30. doi: 10.1002/elps.200900508. 11: Hou J, Zheng J, Shamsi SA. Separation and determination of warfarin enantiomers in human plasma using a novel polymeric surfactant for micellar electrokinetic chromatography-mass spectrometry. J Chromatogr A. 2007 Aug 3;1159(1-2):208-16. Epub 2007 Apr 21. 12: Zheng J, Shamsi SA. Brush-type chiral stationary phase for enantioseparation of acidic compounds. Optimization of chiral capillary electrochromatographic parameters. J Chromatogr A. 2003 Jul 11;1005(1-2):177-87. doi: 10.1016/j.forsciint.2014.08.012. Epub 2014 Aug 20. doi: 10.1016/j.chroma.2010.08.066. Epub 2010 Sep 16. doi: 10.1007/s00216-015-8954-1. Epub 2015 Aug 18. doi: 10.1177/1040638711433354. doi: 10.1155/2016/6053295. Epub 2016 Dec 12.
合成参考文献
参考文献:10.1002/elps.200900508 摘要:Luces CA, Warner IM. Achiral and chiral separations using MEKC, polyelectrolyte multilayer coatings, and mixed mode separation techniques with molecular micelles. Electrophoresis. 2010 Mar;31(6):1036–43.